Catalyst Wire Dossier Catalyst Wire Dossier

Ultomiris (ravulizumab)

ravulizumab · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ultomiris (ravulizumab), covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Real-life Treatment Outcomes of Ravulizumab in PNH

See pricing